Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3917136 | Early Human Development | 2012 | 5 Pages |
Abstract
SummaryCandida infections are a major cause of morbidity and mortality in neonatal intensive care units. Mortality following Candida bloodstream infections is as high as 40%, and neurodevelopmental impairment is common among survivors. Because invasive fungal infections are common and extremely difficult to diagnose, empirical treatment with antifungal therapy should be considered in high-risk, low-birth-weight infants who fail to quickly respond to empirical antibacterial treatment. Risk factors to consider when deciding to administer empirical antifungal therapy include: prior exposure to third-generation cephalosporins, extreme prematurity, and presence of central venous catheters.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health